Engineered receptors for soluble cellular communication and disease sensing
Nature · 20.02.2025 · 638 (8051) · 805-813
DOI: 10.1038/s41586-024-08366-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nature, online erschienen am 14.11.2024. Verfasst von Dan I Piraner und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA. Hauptthemen laut MEDLINE: Cell Communication, Receptors, Chimeric Antigen, Synthetic Biology, Proteolysis. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIBIB NIH HHS, NIGMS NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Despite recent advances in mammalian synthetic biology, there remains a lack of modular synthetic receptors that can robustly respond to soluble ligands and, in turn, activate bespoke cellular functions. Such receptors would have extensive clinical potential to regulate the activity of engineered therapeutic cells, but so far only receptors against cell-surface targets have approached clinical translation 1 . To address this gap, here we adapt a receptor architecture called the synthetic intramembrane proteolysis receptor (SNIPR) for activation by soluble ligands. Our SNIPR platform can be activated by both natural and synthetic soluble factors, with notably low baseline activity and high fold activation, through an endocytic, pH-dependent cleavage mechanism. We demonstrate the therapeutic capabilities of the receptor platform by localizing the activity of chimeric antigen receptor (CAR) T cells to solid tumours in which soluble disease-associated factors are expressed, bypassing the major hurdle of on-target off-tumour toxicity in bystander organs. We further apply the SNIPR platform to engineer fully synthetic signalling networks between cells orthogonal to natural signalling pathways, expanding the scope of synthetic biology. Our design framework enables cellular communication and environmental interactions, extending the capabilities of synthetic cellular networking in clinical and research contexts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA.
- Department of Biochemistry, University of Washington, Seattle, WA, USA.
- Joint Graduate Program in Bioengineering, University of California San Francisco and University of California Berkeley, San Francisco, CA, USA.
- Penn Medical Scientist Training Program, University of Pennsylvania, Philadelphia, PA, USA.
- Department of Otolaryngology, University of California San Francisco, San Francisco, CA, USA.
- Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.
ORCID-Profile: Adam Chazin-Gray, Iowis Zhu, David Lee, Young-Wook Jun, David Baker, Kole T Roybal
Förderung
- NIBIB NIH HHS
- NIGMS NIH HHS
- NIAID NIH HHS
Zitieren
APA
Piraner, D. I., Abedi, M. H., Duran Gonzalez, M. J., Chazin-Gray, A., Lin, A., Zhu, I., Ravindran, P. T., Schlichthaerle, T., Huang, B., Bearchild, T. H., Lee, D., Wyman, S., Jun, Y. W., Baker, D., & Roybal, K. T. (2025). Engineered receptors for soluble cellular communication and disease sensing. Nature, 638(8051), 805-813. https://doi.org/10.1038/s41586-024-08366-0
Vancouver
Piraner DI, Abedi MH, Duran Gonzalez MJ, Chazin-Gray A, Lin A, Zhu I, et al. Engineered receptors for soluble cellular communication and disease sensing. Nature. 2025;638(8051):805-813. doi:10.1038/s41586-024-08366-0
BibTeX
@article{Piraner2025,
author = {Piraner, Dan I and Abedi, Mohamad H and Duran Gonzalez, Maria J and Chazin-Gray, Adam and Lin, Annie and Zhu, Iowis and Ravindran, Pavithran T and Schlichthaerle, Thomas and Huang, Buwei and Bearchild, Tyler H and Lee, David and Wyman, Sarah and Jun, Young-Wook and Baker, David and Roybal, Kole T},
title = {Engineered receptors for soluble cellular communication and disease sensing},
journal = {Nature},
year = {2025},
volume = {638},
number = {8051},
pages = {805--813},
doi = {10.1038/s41586-024-08366-0}
}
EUVIMED